Results 241 to 250 of about 326,057 (302)

Successful fatherhood of males with tyrosine kinase inhibitor-resistant chronic myeloid leukemia taking olverembatinib. [PDF]

Ann Hematol
Yu L, Jiang Q.
europepmc   +1 more source

Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells

, 2015
Pilkington, Geoffrey John, Birt, Matthew, Vouri, Mikaella, Hafizi, Sassan, An, Qian   +4 more
core   +1 more source

Cold Gas Plasma Induces Platelet Activation and Hemostasis in Native and Anticoagulated Human Blood

Advanced NanoBiomed Research, EarlyView.
Cold physical gas plasma induces platelet activation and hemostatic responses in native and anticoagulated human blood. Treatment efficacy depends on plasma parameters, including gas composition, distance, and exposure mode, which govern reactive species delivery and energy transfer.
Sander Bekeschus, Broder Poschkamp, Lea Miebach, Anke Schmidt, Linus Hübner, Julia van der Linde   +5 more
wiley   +1 more source

DGKH-PA-mTOR: A pharmacologically druggable metabolic axis underpinning tyrosine-kinase-inhibitor resistance in hepatocellular carcinoma. [PDF]

ILIVER
Cai F, Zhao B.
europepmc   +1 more source

Olverembatinib (HQP1351): a third-generation tyrosine kinase inhibitor in the treatment of hematologic and solid malignancies-a comprehensive review of clinical outcomes. [PDF]

Discov Oncol
Sadati S, Yazdizadeh S, Razavi SM, Homayoonfal M, Ferns GA, Divani F, Mirzaei H.   +6 more
europepmc   +1 more source

PD-1 blockade plus tyrosine kinase inhibitor remodels the tumor microenvironment in advanced renal cell carcinoma. [PDF]

Nat Commun
Gu L, Zhang Q, Liang Q, Peng C, Wang Y, Wang C, Li Z, Tan Y, Zhou Y, Bi Q, Li X, Luo J, Huang Q, Huang Y, Zhang X, Ma X, Ci W, Wang B.   +17 more
europepmc   +1 more source

Adjuvant epidermal growth factor receptor tyrosine kinase inhibitor in resected stage N2 non-small cell lung cancer harboring <i>EGFR</i> mutation. [PDF]

Transl Lung Cancer Res
Xue Y, Wu Q, Li W, Xu F, Li Y, Zhou Q.
europepmc   +1 more source

Tyrosine Kinase Inhibitor Treatment of a Patient with Chronic Myeloid Leukemia and Congenital Thrombophilia. [PDF]

Hematol Rep
Herrera-Hernández C, Segura-Diaz A, Stuckey R, López-Rodríguez JF, Gómez-Casares MT.   +4 more
europepmc   +1 more source

Recent Advances in Virus–Host Interactions, Antiviral Bioactive Compounds, and Breeding for Disease Resistance of Porcine Epidemic Diarrhea Virus

Animal Research and One Health, EarlyView.
Basic research on the PEDV infection cycle and virus–host interactions advances the development of anti‐PEDV drugs and disease‐resistant breeding and helps strengthen disease prevention and control while reducing economic losses in the swine industry.
Heyong Wu, Aosi Qi, Shuyu Zhong, Haozhen Du, Shimeng Guo, Hongsheng Ouyang, Hongming Yuan, Daxin Pang, Zicong Xie   +8 more
wiley   +1 more source

Epidermal growth factor receptor tyrosine kinase inhibitor for the treatment of non-small cell lung cancer in the past 30 years (1997-2026). [PDF]

Chin Med J (Engl)
Xie Z, Chen X, Gao R, Yang M, Han X, Sun Y, Shi Y.   +6 more
europepmc   +1 more source